Skip to content
10-Q

Quarterly Report

Skye Bioscience, Inc. SKYE

0001516551-25-000049

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 5, 2025 30.99M sh
Shares Diluted Q2 2025 · Jun 30, 2025 39.66M sh
Shares Diluted Q2 2025 · Jun 30, 2025 39.66M sh
Shares Diluted Q2 2025 · Jun 30, 2024 38.67M sh
Shares Diluted Q2 2025 · Jun 30, 2024 33.33M sh
Capex Q2 2025 · Jun 30, 2025 $6.31K
Capex Q2 2025 · Jun 30, 2024 $35.64K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$19.93M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$11.8M
Short Term Investments Q2 2025 · Jun 30, 2025 $24.75M
Short Term Investments Q2 2025 · Dec 31, 2024 $0
Cash And Equivalents Q2 2025 · Jun 30, 2025 $23.84M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $68.42M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $74.12M
Stockholders Equity Q2 2025 · Jun 30, 2025 $43.68M
Stockholders Equity Q2 2025 · Mar 31, 2025 $59.25M
Stockholders Equity Q2 2025 · Dec 31, 2024 $68.15M
Stockholders Equity Q2 2025 · Jun 30, 2024 $72.81M
Stockholders Equity Q2 2025 · Mar 31, 2024 $78.88M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$2.13M
Current Liabilities Q2 2025 · Jun 30, 2025 $8.31M
Current Liabilities Q2 2025 · Dec 31, 2024 $4.34M
Total Liabilities Q2 2025 · Jun 30, 2025 $8.48M
Total Liabilities Q2 2025 · Dec 31, 2024 $4.61M
Current Assets Q2 2025 · Jun 30, 2025 $50.58M
Current Assets Q2 2025 · Dec 31, 2024 $70.83M
Total Assets Q2 2025 · Jun 30, 2025 $52.16M
Total Assets Q2 2025 · Dec 31, 2024 $72.76M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.44
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.72
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.20
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.39
Eps Basic Q2 2025 · Jun 30, 2025 −$0.44
Eps Basic Q2 2025 · Jun 30, 2025 −$0.72
Eps Basic Q2 2025 · Jun 30, 2024 −$0.20
Eps Basic Q2 2025 · Jun 30, 2024 −$0.39
Sga Expense Q2 2025 · Jun 30, 2025 $3.91M
Sga Expense Q2 2025 · Jun 30, 2025 $8.47M
Sga Expense Q2 2025 · Jun 30, 2024 $4.33M
Sga Expense Q2 2025 · Jun 30, 2024 $8.53M
Net Income Q2 2025 · Jun 30, 2025 −$17.62M
Net Income Q2 2025 · Jun 30, 2025 −$28.73M
Net Income Q2 2025 · Mar 31, 2025 −$11.1M
Net Income Q2 2025 · Jun 30, 2024 −$7.9M
Net Income Q2 2025 · Jun 30, 2024 −$12.92M
Net Income Q2 2025 · Mar 31, 2024 −$5.02M
Operating Income Q2 2025 · Jun 30, 2025 −$18.24M
Operating Income Q2 2025 · Jun 30, 2025 −$30M
Operating Income Q2 2025 · Jun 30, 2024 −$8.41M
Operating Income Q2 2025 · Jun 30, 2024 −$14.56M